Table 3.
Group | Zn (μg g−1) | MDA (nmol g−1 wt.w) | GSH (μmol g−1 wt.w) | tGSH (μmol g−1 wt.w) |
---|---|---|---|---|
Control | 59.4 ± 5 | 1.8 ± 0.3 | 42.2 ± 3 | 67 ± 4 |
500 μg L−1 | 70.6 ± 6∗ | 1.06 ± 0.2∗∗ | 59 ± 3.4∗∗∗ | 78 ± 6∗ |
2000 μg L−1 | 99 ± 14∗∗∗,### | 6.1 ± 0.8∗∗∗,### | 22.4 ± 3.8∗∗∗,### | 45.8 ± 3.8∗∗∗,### |
wt.w: wet weight tissue. ∗: P < 0.05, ∗∗: P < 0.01, ∗∗∗: P < 0.001, compared to the control group; #: P < 0.05, ##: P < 0.01, ###: P < 0.001, comparing to 500 μg L−1 of the ZnNP exposed group.